Microcrystalline cellulose

This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.

Identification

Logo pink
Are you a
new drug developer?
Contact us to learn more about our customized products and solutions.
Name
Microcrystalline cellulose
Accession Number
DB14158
Type
Small Molecule
Groups
Approved, Experimental, Investigational
Description

A polysaccharide with glucose units linked as in CELLOBIOSE. It is the chief constituent of plant fibers, cotton being the purest natural form of the substance. As a raw material, it forms the basis for many derivatives used in chromatography, ion exchange materials, explosives manufacturing, and pharmaceutical preparations.

Synonyms
  • Cellulose
  • Cellulose crystalline
  • Cellulose powder
  • Cellulose regenerated
  • Cellulose, microcrystalline
  • Cellulose, powder
  • Cellulose, powdered
  • Hydroxycellulose
  • Powdered cellulose
  • Pyrocellulose
  • Rayon
External IDs
CP-305
Mixture Products
NameIngredientsDosageRouteLabellerMarketing StartMarketing End
Cellzyme Secret Therapy 3845Microcrystalline cellulose (0.0015 g/100mL) + Allantoin (0.145 g/100mL) + Glycerin (5.2 g/100mL)CreamTopicalPHARMACAL-INTERNATIONAL. CO., LTD2017-08-16Not applicableUs
Cellzyme Secret Therapy 3845Microcrystalline cellulose (0.0015 g/100mL) + Allantoin (0.145 g/100mL) + Glycerin (5.2 g/100mL)CreamTopicalPHARMACAL-INTERNATIONAL. CO., LTD2017-08-16Not applicableUs
Categories
UNII
SMD1X3XO9M
CAS number
9004-34-6

Pharmacology

Indication
Not Available
Associated Conditions
Pharmacodynamics
Not Available
Mechanism of action
Not Available
Additional Data Available
Adverse Effects

Comprehensive structured data on known drug adverse effects with statistical prevalence. MedDRA and ICD10 ids are provided for adverse effect conditions and symptoms.

Learn more
Additional Data Available
Contraindications

Structured data covering drug contraindications. Each contraindication describes a scenario in which the drug is not to be used. Includes restrictions on co-administration, contraindicated populations, and more.

Learn more
Additional Data Available
Blackbox Warnings

Structured data representing warnings from the black box section of drug labels. These warnings cover important and dangerous risks, contraindications, or adverse effects.

Learn more
Absorption
Not Available
Volume of distribution
Not Available
Protein binding
Not Available
Metabolism
Not Available
Route of elimination
Not Available
Half life
Not Available
Clearance
Not Available
Toxicity
Not Available
Affected organisms
Not Available
Pathways
Not Available
Pharmacogenomic Effects/ADRs
Not Available

Interactions

Drug Interactions
Not Available
Food Interactions
Not Available

References

General References
Not Available
External Links
Wikipedia
Microcrystalline_cellulose

Clinical Trials

Clinical Trials
PhaseStatusPurposeConditionsCount
1CompletedPreventionOxidative Stress1
1CompletedSupportive CareStable COPD Patients1
1CompletedTreatmentDepression1
1CompletedTreatmentHealthy Male Volunteers1
1CompletedTreatmentHealthy Volunteers1
1CompletedTreatmentPain, Neuropathic1
1CompletedTreatmentSickle Beta 0 Thalassemia / Sickle Cell Disorders / Sickle-Cell; Hb-SC1
1RecruitingTreatmentHealthy Volunteers1
1, 2CompletedTreatmentAcidosis1
1, 2CompletedTreatmentOpioid Dependence1
2CompletedTreatmentAcute Exacerbation of Chronic Bronchitis (AECB) / Acute Tracheobronchitis1
2CompletedTreatmentBack Pain Lower Back Chronic1
2RecruitingPreventionAmnestic / Cognitive Disorders / Delayed Emergence From Anesthesia / Delirium / Delirium, Dementia / Delirium, Dementia, Amnestic, Cognitive Disorders1
2RecruitingTreatmentCessation, Smoking1
2Unknown StatusTreatmentKnee Osteoarthritis (Knee OA)1
2WithdrawnPreventionAging / Inflammatory Reaction1
2, 3Not Yet RecruitingTreatmentAnemias / Epistaxis Nosebleed / Hereditary Haemorrhagic Telangiectasia (HHT)1
2, 3RecruitingPreventionCognitive Function / Older Adults / Physical Function1
3CompletedTreatmentMenière's Disease / Ménière's Vertigo / Vertigo, Aural / Vertigo, Intermittent1
3CompletedTreatmentOsteoarthritis (OA)1
3CompletedTreatmentSmall Fibre Neuropathy1
3Not Yet RecruitingTreatmentChronic / Spinal Cord Injuries (SCI)1
4Active Not RecruitingBasic ScienceArterial hypoxia / Chemoreceptor Apnea / Respiration; Sleep Disorder / Sleep Disordered Breathing (SDB)1
4CompletedBasic ScienceType 2 Diabetes Mellitus1
4CompletedPreventionBMI >30 kg/m2 / Inflammatory Reaction / Insulin Resistance1
4RecruitingHealth Services ResearchGeneral Surgery / Sedation therapy1
4RecruitingOtherCardiovascular Disease (CVD)1
4TerminatedBasic SciencePlatelet Aggregation1
4TerminatedTreatmentClostridium Difficile / Spinal Cord Injuries (SCI)1
Not AvailableCompletedTreatmentObesity, Morbid1
Not AvailableRecruitingTreatmentHigh Blood Pressure (Hypertension) / Type 2 Diabetes Mellitus1
Not AvailableTerminatedPreventionPostpartum Depression1

Pharmacoeconomics

Manufacturers
Not Available
Packagers
Not Available
Dosage forms
FormRouteStrength
CreamTopical
Prices
Not Available
Patents
Not Available

Properties

State
Not Available
Experimental Properties
Not Available
Predicted Properties
Not Available
Predicted ADMET features
Not Available

Spectra

Mass Spec (NIST)
Not Available
Spectra
Not Available

Taxonomy

Classification
Not classified

Drug created on June 29, 2018 09:08 / Updated on May 01, 2019 11:58